Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Understand what your retirement savings goal should be at 30. Ensure a secure financial future with proper planning.
24,773 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Institutional moves shape the AI stock landscape. This article dives into Philippe Laffont’s Coatue strategy, why Nvi...
Mega-cap tech values are under pressure, and the question on many minds is whether Alphabet, Apple, Microsoft kicked ...
As AI reshapes the job landscape in early 2026, workers face displacement and investors recalibrate. This report expl...
A major partnership reshapes Novo Nordisk's growth trajectory. This deep dive explains what the Vivtex deal means for...
As butterfly (BFLY) prepares for 2025 earnings, investors want clarity on growth, margins, and cash runway. This arti...
A major investor stepped into Crocs with a sizable new stake, valuing the position at about $53.7 million even as CRO...
As 2026 looms, investors hunt for clarity in a volatile crypto landscape. From ETH buy-ins by top analysts to evolvin...
When a niche space-data stock jumps, investors want to know the real reasons behind the move. This guide explains why...
In 2026, several of Vanguard's sector ETFs are outperforming the S&P 500. This guide explains why, highlights a March...
Homeowners push for property tax relief as states weigh cuts, but funding gaps and school budgets complicate the poli...
When the broader market fell, one name stood out. This article explains why plug power stock defied the downturn, fea...